Genomictree Inc.
228760
Classificação em ações
#19175
Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to... Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to develop and market advanced detection tools for both oncological conditions and various infectious diseases. Its product line includes EarlyTect C, a screening solution for the early identification of colorectal cancer. For lung cancer, it offers EarlyTect L, which targets epigenetic markers in patients with pulmonary nodules, and for bladder cancer, EarlyTect B, designed to detect specific genetic and epigenetic markers in individuals with hematuria. The company also provides a range of companion diagnostics: AccuraTect-KRAS and AccuraTect-BRAF assist in colorectal cancer management, while AccuraTect-EGFR supports lung cancer treatment. In addition, Genomictree supplies AccuraDTect SARS-CoV-2 RT-qPCR kits for infectious disease testing, and offers its technologies to support various diagnostic test providers. Founded in 2000, the company is based in Daejeon, South Korea.
Preço da ação
$6.61
Valor de mercado
$162.26M
Variação (1 dia)
1.06%
Variação (1 ano)
-50.87%
País
KR
Negociar Genomictree Inc. (228760)
Categoria
Healthcare
Capitalização de mercado de Genomictree Inc.(228760)
Valor de mercado: $162.26M
Em October 2026, Genomictree Inc. tem uma capitalização de mercado de $162.26M. Isso faz com que Genomictree Inc. seja a 19175th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Genomictree Inc. de 2017 a 2026
228760 comparado com o topo de 5 mais populares stocks
